Dear Colleagues and Partners,
We are delighted to welcome you to a virtual venture to the 4th International BRCA Forum(iBRCAf) 2020! As there is a constant need to keep our healthcare experts updated with latest breakthroughs in Medical Education, IBRCAF is officially going virtual to deliver insightful and interactive learning right at the safety of your homes.
As we progress with the infinite possibilities of genetic oncology, BRCA gene mutation is rapidly emerging to become an important agnostic marker for therapy with PARPi with applications in the realm of breast, ovarian and pancreatic cancers. The scientific committee and faculty of iBRCAf for the past three years has been working very hard to bring healthcare professionals under one roof to discuss new research and best practices. Acknowledging that molecular profiling of tumors is rapidly becoming an integral part of management the scientific committee is looking forward to put together a program that will cover a broad-spectrum topic looking at therapeutic targets including BRCA and beyond. How do we test for these targets? Is comprehensive profiling important in every practice? How do we best incorporate them into management strategies? These are a few of the questions we will be asking this year.
This 4th edition of iBRCAf is focused to highlight regional viewpoints into BRCA related malignancies, going beyond BRCA to determine emerging important targets, and to share experiences so we can learn from each other. The two-day program will certainly have something to wet the appetites of everyone and our tumor boards will provide a platform for sharing of practical cases. Our local, regional and international faculty will ensure a highly interactive and fruitful conference.
